Formula: | C19H16F4N4O |
Molecular Weight: | 392.36 |
Rotatable Bond Donors: | 4 |
clogP: | 3.73 |
Topological Polar Surface Area: | 73.80 |
Lipinski's RO5: | MW: 392.36 HBA: 5 HBD: 2 RB: 4 LogP: 3.73 |
Rule of Three: | MW: 392.36 HBA: 5 HBD: 2 RB: 4 LogP: 3.73 |
|
ZINC ID | Similarity | Structure | SDF |
---|
ZINC ID | Similarity | Structure | SDF | |
---|---|---|---|---|
ZINC199512581 | 1.0 | ZINC199512581 RDKit 3D 28 30 0 0 0 0 0 0 0 0999 V2000 -3.6355 2.4883 1.7819 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.6475 1.2954 0.8849 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.4842 0.5224 0.8344 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.4146 -0.6082 0.0199 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.2244 -1.3641 -0.0071 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.1574 -1.0033 0.7492 N 0 0 0 0 0 0 0 0 0 0 0 0 0.7515 -1.9301 0.4341 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1075 -1.9547 1.0353 C 0 0 0 0 0 0 0 0 0 0 0 0 2.9959 -1.2214 0.0770 C 0 0 0 0 0 0 0 0 0 0 0 0 3.6966 -1.9246 -0.9039 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5358 -1.2358 -1.7724 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2113 -1.9094 -2.7126 F 0 0 0 0 0 0 0 0 0 0 0 0 4.6929 0.1428 -1.6729 C 0 0 0 0 0 0 0 0 0 0 0 0 3.9964 0.8541 -0.6942 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1909 2.3308 -0.5540 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2217 2.6391 0.2803 F 0 0 0 0 0 0 0 0 0 0 0 0 3.0993 2.9726 -0.0529 F 0 0 0 0 0 0 0 0 0 0 0 0 4.4691 2.9486 -1.7358 F 0 0 0 0 0 0 0 0 0 0 0 0 3.1631 0.1622 0.1884 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3222 -2.8806 -0.4478 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.9110 -2.5085 -0.7207 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8281 -3.2021 -1.6452 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.5115 -0.9721 -0.7515 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.6741 -0.2061 -0.7058 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.7571 0.9302 0.1077 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.0277 1.7095 0.1163 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.0110 1.2182 -0.7143 N 0 0 0 0 0 0 0 0 0 0 0 0 -6.1701 2.7069 0.8144 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 2 0 3 4 1 0 4 5 1 0 5 6 1 0 6 7 2 0 7 8 1 0 8 9 1 0 9 10 2 0 10 11 1 0 11 12 1 0 11 13 2 0 13 14 1 0 14 15 1 0 15 16 1 0 15 17 1 0 15 18 1 0 14 19 2 0 7 20 1 0 20 21 2 0 21 22 1 0 4 23 2 0 23 24 1 0 24 25 2 0 25 26 1 0 26 27 1 0 26 28 2 0 25 2 1 0 21 5 1 0 19 9 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
Single dose inhibition of SARS-CoV-2 cytopathic effect in VeroE6 | primary assay | Organism Severe acute respiratory syndrome-related coronavirus | inactive |
Single dose inhibition of SARS-CoV-2 3CL-Pro | primary assay | Replicase polyprotein 1ab | inactive |